Literature DB >> 16482500

Multitasking by multivalent circular DNA aptamers.

Daniel A Di Giusto1, Sarah M Knox, Yuching Lai, Gregory D Tyrelle, May T Aung, Garry C King.   

Abstract

Nucleic acid aptamers are finding increasing applications in biology, especially as therapeutic candidates and diagnostic components. An important characteristic in meeting the needs of these applications is improved stability in physiological fluids, which is most often accomplished with chemical modification or unnatural nucleotides. In an alternative approach we have specified the design of a multivalent circular DNA aptamer topology that encompasses a number of properties relevant to nucleic acid therapeutic candidates, especially the ability to multitask by combining different activities together within a modular structure. Improved stability in blood products, greater conformational stability, antidoting by complementary circular antiaptamers, heterovalency, transcription factor decoy activity and minimal unintended effects upon the cellular innate immune response are desirable properties that are described here. Multitasking by circular DNA aptamers could similarly find applications in diagnostics and biomaterials, where the combination of interchangeable modules might generate new functions, such as anticoagulation coupled with reversible cell capture as, described here. These results provide a platform for further exploration of multivalent circular aptamer properties, especially in novel combinations of nucleic acid therapeutic modes.

Mesh:

Substances:

Year:  2006        PMID: 16482500     DOI: 10.1002/cbic.200500316

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  9 in total

Review 1.  Functional nucleic acid sensors.

Authors:  Juewen Liu; Zehui Cao; Yi Lu
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

2.  Aptamers: problems, solutions and prospects.

Authors:  A V Lakhin; V Z Tarantul; L V Gening
Journal:  Acta Naturae       Date:  2013-10       Impact factor: 1.845

3.  Bi-specific aptamers mediating tumor cell lysis.

Authors:  Achim Boltz; Birgit Piater; Lars Toleikis; Ralf Guenther; Harald Kolmar; Bjoern Hock
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

Review 4.  Fluorescent DNA-based enzyme sensors.

Authors:  Nan Dai; Eric T Kool
Journal:  Chem Soc Rev       Date:  2011-02-02       Impact factor: 54.564

5.  Enrichment of cancer cells using aptamers immobilized on a microfluidic channel.

Authors:  Joseph A Phillips; Ye Xu; Zheng Xia; Z Hugh Fan; Weihong Tan
Journal:  Anal Chem       Date:  2009-02-01       Impact factor: 6.986

Review 6.  Aptamer Therapeutics in Cancer: Current and Future.

Authors:  Yoshihiro Morita; Macall Leslie; Hiroyasu Kameyama; David E Volk; Takemi Tanaka
Journal:  Cancers (Basel)       Date:  2018-03-19       Impact factor: 6.639

Review 7.  Dimeric and Multimeric DNA Aptamers for Highly Effective Protein Recognition.

Authors:  Claudia Riccardi; Ettore Napolitano; Domenica Musumeci; Daniela Montesarchio
Journal:  Molecules       Date:  2020-11-10       Impact factor: 4.411

8.  CD16/PD-L1 bi-specific aptamer for cancer immunotherapy through recruiting NK cells and acting as immunocheckpoint blockade.

Authors:  Aixian Zheng; Yanlin Du; Yiru Wang; Youshi Zheng; Zhaoyu Ning; Ming Wu; Cuilin Zhang; Da Zhang; Jingfeng Liu; Xiaolong Liu
Journal:  Mol Ther Nucleic Acids       Date:  2022-01-19       Impact factor: 8.886

9.  Circular and linear: a tale of aptamer selection for the activation of SIRT1 to induce death in cancer cells.

Authors:  Basma Al-Sudani; Abby H Ragazzon-Smith; Athar Aziz; Rania Alansari; Natalie Ferry; Marija Krstic-Demonacos; Patricia A Ragazzon
Journal:  RSC Adv       Date:  2020-12-21       Impact factor: 4.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.